Please use this identifier to cite or link to this item: https://hdl.handle.net/1/2723
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMorrow, Andrew-
dc.contributor.authorYoung, Robin-
dc.contributor.authorAbraham, George R-
dc.contributor.authorHoole, Stephen-
dc.contributor.authorGreenwood, John P-
dc.contributor.authorArnold, Jayanth Ranjit-
dc.contributor.authorEl Shibly, Mohamed-
dc.contributor.authorShanmuganathan, Mayooran-
dc.contributor.authorFerreira, Vanessa-
dc.contributor.authorRakhit, Roby-
dc.contributor.authorGalasko, Gavin-
dc.contributor.authorSinha, Aish-
dc.contributor.authorPerera, Divaka-
dc.contributor.authorAl-Lamee, Rasha-
dc.contributor.authorSpyridopoulos, Ioakim-
dc.contributor.authorKotecha, Ashish-
dc.contributor.authorClesham, Gerald-
dc.contributor.authorFord, Tom-
dc.contributor.authorDavenport, Anthony-
dc.contributor.authorPadmanabhan, Sandosh-
dc.contributor.authorJolly, Lisa-
dc.contributor.authorKellman, Peter-
dc.contributor.authorKaski, Juan Carlos-
dc.contributor.authorWeir, Robin A-
dc.contributor.authorSattar, Naveed-
dc.contributor.authorKennedy, Julie-
dc.contributor.authorMacfarlane, Peter W-
dc.contributor.authorWelsh, Paul-
dc.contributor.authorMcConnachie, Alex-
dc.contributor.authorBerry, Colin-
dc.date.accessioned2024-09-05T04:58:27Z-
dc.date.available2024-09-05T04:58:27Z-
dc.date.issued2024-09-01-
dc.identifier.citationOnline ahead of printen
dc.identifier.urihttps://hdl.handle.net/1/2723-
dc.description.abstractBackground: Microvascular angina is associated with dysregulation of the endothelin system and impairments in myocardial blood flow, exercise capacity, and health-related quality of life. The G allele of the noncoding single nucleotide polymorphism RS9349379 enhances expression of the endothelin-1 gene (EDN1) in human vascular cells, potentially increasing circulating concentrations of Endothelin-1 (ET-1). Whether zibotentan, an oral ET-A receptor selective antagonist, is efficacious and safe for the treatment of microvascular angina is unknown. Methods: Patients with microvascular angina were enrolled in this double-blind, placebo-controlled, sequential crossover trial of zibotentan (10 mg daily for 12 weeks). The trial population was enriched to ensure a G allele frequency of 50% for the RS9349379 single nucleotide polymorphism. Participants and investigators were blinded to genotype. The primary outcome was treadmill exercise duration (seconds) using the Bruce protocol. The primary analysis estimated the mean within-participant difference in exercise duration after treatment with zibotentan versus placebo. Results: A total of 118 participants (mean ±SD; years of age 63.5 [9.2 ]; 71 [60.2% ] females; 25 [21.2% ] with diabetes) were randomized. Among 103 participants with complete data, the mean exercise duration with zibotentan treatment compared with placebo was not different (between-treatment difference, -4.26 seconds [95 ] CI, -19.60 to 11.06] P=0.5871). Secondary outcomes showed no improvement with zibotentan. Zibotentan reduced blood pressure and increased plasma concentrations of ET-1. Adverse events were more common with zibotentan (60.2%) compared with placebo (14.4%; P<0.001). Conclusions: Among patients with microvascular angina, short-term treatment with a relatively high dose (10 mg daily) of zibotentan was not beneficial. Target-related adverse effects were common.en
dc.description.sponsorshipCardiologyen
dc.subjectCardiologyen
dc.subjectCardiovascular Diseaseen
dc.titleZibotentan in Microvascular Angina: A Randomized, Placebo-Controlled, Crossover Trialen
dc.typeJournal Articleen
dc.identifier.doi10.1161/CIRCULATIONAHA.124.069901en
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/39217504en
dc.description.affiliatesCentral Coast Local Health Districten
dc.description.affiliatesGosford Hospitalen
dc.identifier.journaltitleCirculationen
dc.type.studyortrialRandomized Controlled Clinical Trial/Controlled Clinical Trialen
dc.type.contentTexten
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptCardiology-
Appears in Collections:Health Service Research
Show simple item record

Page view(s)

20
checked on Oct 6, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.